Jayapal Reddy Mallareddy

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Cell Cycle Arrest

Chronic Lymphocytic Leukemia

Endoplasmic Reticulum

Top Venues

Cancer research communications

Proceedings of the National Academy of Sciences of the United States of America

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Alexandria P Eiken, Audrey L Smith, Sydney A Skupa, Elizabeth Schmitz, Sandeep Rana, Yongseok Choi, Siddhartha Kumar, Jayapal Reddy Mallareddy, Aguirre A de Cubas, Akshay Krishna, Achyuth Kalluchi, M Jordan Rowley, Christopher R D'Angelo, Matthew A Lunning, R Gregory Bociek, Julie M Vose, Amarnath Natarajan, Dalia El-Gamal
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects. Cancer research communications 4 (5) (2024)
Alexandria P Eiken, Audrey L Smith, Sydney A Skupa, Elizabeth Schmitz, Sandeep Rana, Yongseok Choi, Siddhartha Kumar, Jayapal Reddy Mallareddy, Aguirre A de Cubas, Akshay Krishna, Achyuth Kalluchi, M Jordan Rowley, Christopher R D'Angelo, Matthew A Lunning, R Gregory Bociek, Julie M Vose, Amarnath Natarajan, Dalia El-Gamal
Novel spirocyclic dimer, SpiD3, targets chronic lymphocytic leukemia survival pathways with potent preclinical effects. Cancer research communications (2024)
Alexandria P Eiken, Audrey L Smith, Sydney A Skupa, Elizabeth Schmitz, Sandeep Rana, Yongseok Choi, Siddhartha Kumar, Jayapal Reddy Mallareddy, Aguirre A de Cubas, Akshay Krishna, Achyuth Kalluchi, M Jordan Rowley, Christopher R D'Angelo, Matthew A Lunning, R Gregory Bociek, Julie M Vose, Amarnath Natarajan, Dalia El-Gamal
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects. Cancer research communications 4 (5) (2024)
John Victor Napoleon, Satish Sagar, Sydney P Kubica, Lidia Boghean, Smit Kour, Hannah M King, Yogesh A Sonawane, Ayrianne J Crawford, Nagsen Gautam, Smitha Kizhake, Pawel A Bialk, Eric Kmiec, Jayapal Reddy Mallareddy, Prathamesh P Patil, Sandeep Rana, Sarbjit Singh, Janani Prahlad, Paul M Grandgenett, Gloria E O Borgstahl, Gargi Ghosal, Yazen Alnouti, Michael A Hollingsworth, Prakash Radhakrishnan, Amarnath Natarajan
Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growth. Proceedings of the National Academy of Sciences of the United States of America 119 (18) (2022)
Sandeep Rana, Jayapal Reddy Mallareddy, Sarbjit Singh, Lidia Boghean, Amarnath Natarajan
Inhibitors, PROTACs and Molecular Glues as Diverse Therapeutic Modalities to Target Cyclin-Dependent Kinase. Cancers 13 (21) (2021)
Jayapal Reddy Mallareddy, Sarbjit Singh, Lidia Boghean, Amarnath Natarajan
Selective CDK9 degradation using a proteolysis-targeting chimera (PROTAC) strategy. Future medicinal chemistry (2021)